10-Q Filing

SOLENO THERAPEUTICS INC CIK: 1484565 Q2 2025

Filing Information

Form Type	10-Q
Accession Number	`0000950170-25-104220`
Period End Date	20250630
Filing Date	20250806
Fiscal Year	2025
Fiscal Period	Q2
XBRL Instance	slno-20250630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 162 Income Statement 140 Cash Flow Statement 138 Stockholders Equity 86

Balance Sheet 162 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	45.70M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	45.70M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$87.93M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$87.93M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	50.44M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	50.44M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$76.50M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$76.50M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$210.34M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$210.34M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$203.51M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$203.51M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	50.44M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	50.44M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	45.70M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	45.70M	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$24.62M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$24.62M	USD	Point-in-time
Inventory	`InventoryNet`	$2.35M	USD	Point-in-time
Inventory	`InventoryNet`	$2.35M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$2.45M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$2.45M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$2.97M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$2.97M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$316.79M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$316.79M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$293.89M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$293.89M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$186.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$186.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$166.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$166.00K	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$2.43M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$2.43M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$2.80M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$2.80M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$6.80M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$6.80M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$5.83M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$5.83M	USD	Point-in-time
Long-term marketable securities	`MarketableSecuritiesNoncurrent`	$7.00M	USD	Point-in-time
Long-term marketable securities	`MarketableSecuritiesNoncurrent`	$7.00M	USD	Point-in-time
Long-term marketable securities	`MarketableSecuritiesNoncurrent`	$27.21M	USD	Point-in-time
Long-term marketable securities	`MarketableSecuritiesNoncurrent`	$27.21M	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$83.00K	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$83.00K	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$83.00K	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$83.00K	USD	Point-in-time
Total assets	`Assets`	$330.97M	USD	Point-in-time
Total assets	`Assets`	$330.97M	USD	Point-in-time
Total assets	`Assets`	$332.31M	USD	Point-in-time
Total assets	`Assets`	$332.31M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$8.88M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$8.88M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$6.22M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$6.22M	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$6.27M	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$6.27M	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$4.78M	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$4.78M	USD	Point-in-time
Accrued clinical trial site costs	`AccruedClinicalTrialCostsCurrent`	$1.86M	USD	Point-in-time
Accrued clinical trial site costs	`AccruedClinicalTrialCostsCurrent`	$1.86M	USD	Point-in-time
Accrued clinical trial site costs	`AccruedClinicalTrialCostsCurrent`	$1.83M	USD	Point-in-time
Accrued clinical trial site costs	`AccruedClinicalTrialCostsCurrent`	$1.83M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$676.00K	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$676.00K	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$526.00K	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$526.00K	USD	Point-in-time
Accrued interest payable	`InterestPayableCurrent`	$409.00K	USD	Point-in-time
Accrued interest payable	`InterestPayableCurrent`	$409.00K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$5.51M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$5.51M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$2.74M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$2.74M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$20.94M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$20.94M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$18.75M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$18.75M	USD	Point-in-time
Contingent liability for Essentialis purchase price	`AssetAcquisitionContingentConsiderationLiabilityNoncurrent`	$18.86M	USD	Point-in-time
Contingent liability for Essentialis purchase price	`AssetAcquisitionContingentConsiderationLiabilityNoncurrent`	$18.86M	USD	Point-in-time
Contingent liability for Essentialis purchase price	`AssetAcquisitionContingentConsiderationLiabilityNoncurrent`	$14.79M	USD	Point-in-time
Contingent liability for Essentialis purchase price	`AssetAcquisitionContingentConsiderationLiabilityNoncurrent`	$14.79M	USD	Point-in-time
Long-term debt, net	`LongTermDebtNoncurrent`	$49.84M	USD	Point-in-time
Long-term debt, net	`LongTermDebtNoncurrent`	$49.84M	USD	Point-in-time
Long-term debt, net	`LongTermDebtNoncurrent`	$49.83M	USD	Point-in-time
Long-term debt, net	`LongTermDebtNoncurrent`	$49.83M	USD	Point-in-time
Long-term lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$2.47M	USD	Point-in-time
Long-term lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$2.47M	USD	Point-in-time
Long-term lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$2.25M	USD	Point-in-time
Long-term lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$2.25M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$271.00K	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$271.00K	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$21.00K	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$21.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$85.86M	USD	Point-in-time
Total liabilities	`Liabilities`	$85.86M	USD	Point-in-time
Total liabilities	`Liabilities`	$92.17M	USD	Point-in-time
Total liabilities	`Liabilities`	$92.17M	USD	Point-in-time
Commitments and contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 10,000,000 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 10,000,000 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 10,000,000 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 10,000,000 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value, 100,000,000 shares authorized, 50,437,066 and 45,703,811 shares issued and outstanding at June 30, 2025 and December 31, 2024, respectively	`CommonStockValue`	$50.00K	USD	Point-in-time
Common stock, $0.001 par value, 100,000,000 shares authorized, 50,437,066 and 45,703,811 shares issued and outstanding at June 30, 2025 and December 31, 2024, respectively	`CommonStockValue`	$50.00K	USD	Point-in-time
Common stock, $0.001 par value, 100,000,000 shares authorized, 50,437,066 and 45,703,811 shares issued and outstanding at June 30, 2025 and December 31, 2024, respectively	`CommonStockValue`	$46.00K	USD	Point-in-time
Common stock, $0.001 par value, 100,000,000 shares authorized, 50,437,066 and 45,703,811 shares issued and outstanding at June 30, 2025 and December 31, 2024, respectively	`CommonStockValue`	$46.00K	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapitalCommonStock`	$740.75M	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapitalCommonStock`	$740.75M	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapitalCommonStock`	$696.97M	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapitalCommonStock`	$696.97M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$361.00K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$361.00K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$85.00K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$85.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-500.74M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-500.74M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-452.26M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-452.26M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$157.51M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$157.51M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$245.11M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$245.11M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$280.76M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$280.76M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$240.14M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$240.14M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$143.39M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$143.39M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$232.26M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$232.26M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$332.31M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$332.31M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$330.97M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$330.97M	USD	Point-in-time

Income Statement 140 line items

Line Item	Tag	Value	Unit	Period
Total revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$32.66M	USD	2 Qtrs
Total revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$32.66M	USD	2 Qtrs
Total revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$32.66M	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$32.66M	USD	1 Quarter
Cost of goods sold	`CostOfRevenue`	$696.00K	USD	1 Quarter
Cost of goods sold	`CostOfRevenue`	$696.00K	USD	1 Quarter
Cost of goods sold	`CostOfRevenue`	$696.00K	USD	2 Qtrs
Cost of goods sold	`CostOfRevenue`	$696.00K	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$22.66M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$22.66M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$12.34M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$12.34M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$26.94M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$26.94M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$9.15M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$9.15M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$28.24M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$28.24M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$10.89M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$10.89M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$19.36M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$19.36M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$57.50M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$57.50M	USD	2 Qtrs
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$1.64M	USD	1 Quarter
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$1.64M	USD	1 Quarter
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$1.10M	USD	1 Quarter
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$1.10M	USD	1 Quarter
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$4.07M	USD	2 Qtrs
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$4.07M	USD	2 Qtrs
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$2.04M	USD	2 Qtrs
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$2.04M	USD	2 Qtrs
Total operating expenses	`CostsAndExpenses`	$39.18M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$39.18M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$48.34M	USD	2 Qtrs
Total operating expenses	`CostsAndExpenses`	$48.34M	USD	2 Qtrs
Total operating expenses	`CostsAndExpenses`	$84.92M	USD	2 Qtrs
Total operating expenses	`CostsAndExpenses`	$84.92M	USD	2 Qtrs
Total operating expenses	`CostsAndExpenses`	$24.87M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$24.87M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-48.34M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-48.34M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-52.27M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-52.27M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-6.53M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-6.53M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-24.87M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-24.87M	USD	1 Quarter
Interest income, net	`InvestmentIncomeInterest`	$6.52M	USD	2 Qtrs
Interest income, net	`InvestmentIncomeInterest`	$6.52M	USD	2 Qtrs
Interest income, net	`InvestmentIncomeInterest`	$5.09M	USD	2 Qtrs
Interest income, net	`InvestmentIncomeInterest`	$5.09M	USD	2 Qtrs
Interest income, net	`InvestmentIncomeInterest`	$3.19M	USD	1 Quarter
Interest income, net	`InvestmentIncomeInterest`	$3.19M	USD	1 Quarter
Interest income, net	`InvestmentIncomeInterest`	$3.01M	USD	1 Quarter
Interest income, net	`InvestmentIncomeInterest`	$3.01M	USD	1 Quarter
Interest expense	`InterestExpenseNonoperating`	$1.38M	USD	1 Quarter
Interest expense	`InterestExpenseNonoperating`	$1.38M	USD	1 Quarter
Interest expense	`InterestExpenseNonoperating`	$2.74M	USD	2 Qtrs
Interest expense	`InterestExpenseNonoperating`	$2.74M	USD	2 Qtrs
Total other income (expense), net	`NonoperatingIncomeExpense`	$3.79M	USD	2 Qtrs
Total other income (expense), net	`NonoperatingIncomeExpense`	$3.79M	USD	2 Qtrs
Total other income (expense), net	`NonoperatingIncomeExpense`	$5.09M	USD	2 Qtrs
Total other income (expense), net	`NonoperatingIncomeExpense`	$5.09M	USD	2 Qtrs
Total other income (expense), net	`NonoperatingIncomeExpense`	$3.01M	USD	1 Quarter
Total other income (expense), net	`NonoperatingIncomeExpense`	$3.01M	USD	1 Quarter
Total other income (expense), net	`NonoperatingIncomeExpense`	$1.82M	USD	1 Quarter
Total other income (expense), net	`NonoperatingIncomeExpense`	$1.82M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-43.77M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-43.77M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-4.71M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-4.71M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-21.85M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-21.85M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-43.25M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-43.25M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-48.48M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-48.48M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-21.40M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-21.40M	USD	1 Quarter
Net unrealized loss on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-151.00K	USD	2 Qtrs
Net unrealized loss on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-151.00K	USD	2 Qtrs
Net unrealized loss on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-46.00K	USD	1 Quarter
Net unrealized loss on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-46.00K	USD	1 Quarter
Net unrealized loss on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-153.00K	USD	1 Quarter
Net unrealized loss on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-153.00K	USD	1 Quarter
Net unrealized loss on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-292.00K	USD	2 Qtrs
Net unrealized loss on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-292.00K	USD	2 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-1.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-1.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$4.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$4.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$12.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$12.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-1.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-1.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$16.00K	USD	2 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$16.00K	USD	2 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-2.00K	USD	2 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-2.00K	USD	2 Qtrs
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-4.85M	USD	1 Quarter
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-4.85M	USD	1 Quarter
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-48.76M	USD	2 Qtrs
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-48.76M	USD	2 Qtrs
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-21.90M	USD	1 Quarter
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-21.90M	USD	1 Quarter
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-43.41M	USD	2 Qtrs
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-43.41M	USD	2 Qtrs
Net loss per common share basic	`EarningsPerShareBasic`	$-1.16	USD	2 Qtrs
Net loss per common share basic	`EarningsPerShareBasic`	$-1.16	USD	2 Qtrs
Net loss per common share basic	`EarningsPerShareBasic`	$-0.57	USD	1 Quarter
Net loss per common share basic	`EarningsPerShareBasic`	$-0.57	USD	1 Quarter
Net loss per common share basic	`EarningsPerShareBasic`	$-0.09	USD	1 Quarter
Net loss per common share basic	`EarningsPerShareBasic`	$-0.09	USD	1 Quarter
Net loss per common share basic	`EarningsPerShareBasic`	$-1.00	USD	2 Qtrs
Net loss per common share basic	`EarningsPerShareBasic`	$-1.00	USD	2 Qtrs
Net loss per common share diluted	`EarningsPerShareDiluted`	$-0.57	USD	1 Quarter
Net loss per common share diluted	`EarningsPerShareDiluted`	$-0.57	USD	1 Quarter
Net loss per common share diluted	`EarningsPerShareDiluted`	$-1.00	USD	2 Qtrs
Net loss per common share diluted	`EarningsPerShareDiluted`	$-1.00	USD	2 Qtrs
Net loss per common share diluted	`EarningsPerShareDiluted`	$-0.09	USD	1 Quarter
Net loss per common share diluted	`EarningsPerShareDiluted`	$-0.09	USD	1 Quarter
Net loss per common share diluted	`EarningsPerShareDiluted`	$-1.16	USD	2 Qtrs
Net loss per common share diluted	`EarningsPerShareDiluted`	$-1.16	USD	2 Qtrs
Weighted-average common shares outstanding used to calculate basic net loss per common share	`WeightedAverageNumberOfSharesOutstandingBasic`	50.48M	shares	1 Quarter
Weighted-average common shares outstanding used to calculate basic net loss per common share	`WeightedAverageNumberOfSharesOutstandingBasic`	50.48M	shares	1 Quarter
Weighted-average common shares outstanding used to calculate basic net loss per common share	`WeightedAverageNumberOfSharesOutstandingBasic`	38.63M	shares	1 Quarter
Weighted-average common shares outstanding used to calculate basic net loss per common share	`WeightedAverageNumberOfSharesOutstandingBasic`	38.63M	shares	1 Quarter
Weighted-average common shares outstanding used to calculate basic net loss per common share	`WeightedAverageNumberOfSharesOutstandingBasic`	37.42M	shares	2 Qtrs
Weighted-average common shares outstanding used to calculate basic net loss per common share	`WeightedAverageNumberOfSharesOutstandingBasic`	37.42M	shares	2 Qtrs
Weighted-average common shares outstanding used to calculate basic net loss per common share	`WeightedAverageNumberOfSharesOutstandingBasic`	48.34M	shares	2 Qtrs
Weighted-average common shares outstanding used to calculate basic net loss per common share	`WeightedAverageNumberOfSharesOutstandingBasic`	48.34M	shares	2 Qtrs
Weighted-average common shares outstanding used to calculate diluted net loss per common share	`WeightedAverageNumberOfDilutedSharesOutstanding`	48.34M	shares	2 Qtrs
Weighted-average common shares outstanding used to calculate diluted net loss per common share	`WeightedAverageNumberOfDilutedSharesOutstanding`	48.34M	shares	2 Qtrs
Weighted-average common shares outstanding used to calculate diluted net loss per common share	`WeightedAverageNumberOfDilutedSharesOutstanding`	50.48M	shares	1 Quarter
Weighted-average common shares outstanding used to calculate diluted net loss per common share	`WeightedAverageNumberOfDilutedSharesOutstanding`	50.48M	shares	1 Quarter
Weighted-average common shares outstanding used to calculate diluted net loss per common share	`WeightedAverageNumberOfDilutedSharesOutstanding`	37.42M	shares	2 Qtrs
Weighted-average common shares outstanding used to calculate diluted net loss per common share	`WeightedAverageNumberOfDilutedSharesOutstanding`	37.42M	shares	2 Qtrs
Weighted-average common shares outstanding used to calculate diluted net loss per common share	`WeightedAverageNumberOfDilutedSharesOutstanding`	38.63M	shares	1 Quarter
Weighted-average common shares outstanding used to calculate diluted net loss per common share	`WeightedAverageNumberOfDilutedSharesOutstanding`	38.63M	shares	1 Quarter

Cash Flow Statement 138 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-48.48M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-48.48M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-43.25M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-43.25M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$494.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$494.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$984.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$984.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$1.01M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$1.01M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$502.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$502.00K	USD	1 Quarter
Accretion of premium/discount on marketable securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$1.59M	USD	2 Qtrs
Accretion of premium/discount on marketable securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$1.59M	USD	2 Qtrs
Accretion of premium/discount on marketable securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$1.95M	USD	2 Qtrs
Accretion of premium/discount on marketable securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$1.95M	USD	2 Qtrs
Non-cash lease expense	`NoncashLeaseExpense`	$70.00K	USD	1 Quarter
Non-cash lease expense	`NoncashLeaseExpense`	$70.00K	USD	1 Quarter
Non-cash lease expense	`NoncashLeaseExpense`	$364.00K	USD	2 Qtrs
Non-cash lease expense	`NoncashLeaseExpense`	$364.00K	USD	2 Qtrs
Non-cash lease expense	`NoncashLeaseExpense`	$139.00K	USD	2 Qtrs
Non-cash lease expense	`NoncashLeaseExpense`	$139.00K	USD	2 Qtrs
Non-cash lease expense	`NoncashLeaseExpense`	$169.00K	USD	1 Quarter
Non-cash lease expense	`NoncashLeaseExpense`	$169.00K	USD	1 Quarter
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$17.00K	USD	2 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$17.00K	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$7.16M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$7.16M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$9.70M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$9.70M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$24.38M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$24.38M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$13.61M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$13.61M	USD	2 Qtrs
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$1.64M	USD	1 Quarter
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$1.64M	USD	1 Quarter
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$1.10M	USD	1 Quarter
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$1.10M	USD	1 Quarter
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$4.07M	USD	2 Qtrs
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$4.07M	USD	2 Qtrs
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$2.04M	USD	2 Qtrs
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$2.04M	USD	2 Qtrs
Other non-cash reconciling items	`OtherNoncashIncomeExpense`	$2.00K	USD	2 Qtrs
Other non-cash reconciling items	`OtherNoncashIncomeExpense`	$2.00K	USD	2 Qtrs
Other non-cash reconciling items	`OtherNoncashIncomeExpense`	$-16.00K	USD	2 Qtrs
Other non-cash reconciling items	`OtherNoncashIncomeExpense`	$-16.00K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$24.62M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$24.62M	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$2.10M	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$2.10M	USD	2 Qtrs
Prepaid expenses, other current assets and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-380.00K	USD	2 Qtrs
Prepaid expenses, other current assets and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-380.00K	USD	2 Qtrs
Prepaid expenses, other current assets and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$339.00K	USD	2 Qtrs
Prepaid expenses, other current assets and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$339.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$567.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$567.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-2.60M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-2.60M	USD	2 Qtrs
Accrued compensation	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-986.00K	USD	2 Qtrs
Accrued compensation	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-986.00K	USD	2 Qtrs
Accrued compensation	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$1.49M	USD	2 Qtrs
Accrued compensation	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$1.49M	USD	2 Qtrs
Accrued clinical trial site costs	`IncreaseDecreaseInAccruedClinicalTrialSiteCosts`	$-1.53M	USD	2 Qtrs
Accrued clinical trial site costs	`IncreaseDecreaseInAccruedClinicalTrialSiteCosts`	$-1.53M	USD	2 Qtrs
Accrued clinical trial site costs	`IncreaseDecreaseInAccruedClinicalTrialSiteCosts`	$37.00K	USD	2 Qtrs
Accrued clinical trial site costs	`IncreaseDecreaseInAccruedClinicalTrialSiteCosts`	$37.00K	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-107.00K	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-107.00K	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-74.00K	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-74.00K	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$3.43M	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$3.43M	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-429.00K	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-429.00K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-45.36M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-45.36M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-30.18M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-30.18M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$14.00K	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$14.00K	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$19.00K	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$19.00K	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$104.76M	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$104.76M	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$261.15M	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$261.15M	USD	2 Qtrs
Maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$25.00M	USD	2 Qtrs
Maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$25.00M	USD	2 Qtrs
Maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$119.80M	USD	2 Qtrs
Maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$119.80M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$15.02M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$15.02M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-236.16M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-236.16M	USD	2 Qtrs
Payment of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$62.00K	USD	2 Qtrs
Payment of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$62.00K	USD	2 Qtrs
Payment of deferred financing costs	`PaymentOfDeferredFinancingCosts`	$178.00K	USD	2 Qtrs
Payment of deferred financing costs	`PaymentOfDeferredFinancingCosts`	$178.00K	USD	2 Qtrs
Proceeds from the sale of common stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$148.96M	USD	2 Qtrs
Proceeds from the sale of common stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$148.96M	USD	2 Qtrs
Proceeds from exercise of common stock warrants	`ProceedsFromWarrantExercises`	$5.19M	USD	2 Qtrs
Proceeds from exercise of common stock warrants	`ProceedsFromWarrantExercises`	$5.19M	USD	2 Qtrs
Proceeds from exercise of common stock and pre-funded stock warrants	`ProceedsFromExerciseOfCommonStockAndPreFundedStockWarrants`	$3.54M	USD	2 Qtrs
Proceeds from exercise of common stock and pre-funded stock warrants	`ProceedsFromExerciseOfCommonStockAndPreFundedStockWarrants`	$3.54M	USD	2 Qtrs
Proceeds received prior to and for the issuance of common stock and pre-funded warrants	`ProceedsReceivedPriorToForIssuanceOfCommonStockAndPreFundedWarrants`	$637.00K	USD	2 Qtrs
Proceeds received prior to and for the issuance of common stock and pre-funded warrants	`ProceedsReceivedPriorToForIssuanceOfCommonStockAndPreFundedWarrants`	$637.00K	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$552.00K	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$552.00K	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$13.99M	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$13.99M	USD	2 Qtrs
Tax withholding payments for net share-settled equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$33.00K	USD	2 Qtrs
Tax withholding payments for net share-settled equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$33.00K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$18.91M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$18.91M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$153.69M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$153.69M	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-112.66M	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-112.66M	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-11.43M	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-11.43M	USD	2 Qtrs
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$87.93M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$87.93M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$169.68M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$169.68M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$57.02M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$57.02M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$76.50M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$76.50M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$87.93M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$87.93M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$169.68M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$169.68M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$57.02M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$57.02M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$76.50M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$76.50M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$2.06M	USD	2 Qtrs
Cash paid for interest	`InterestPaidNet`	$2.06M	USD	2 Qtrs

Stockholders Equity 86 line items

Line Item	Tag	Value	Unit	Period
Less transaction costs	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$9.75M	USD	1 Quarter
Less transaction costs	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$9.75M	USD	1 Quarter
Balances at beginning	`StockholdersEquity`	$157.51M	USD	Point-in-time
Balances at beginning	`StockholdersEquity`	$157.51M	USD	Point-in-time
Balances at beginning	`StockholdersEquity`	$245.11M	USD	Point-in-time
Balances at beginning	`StockholdersEquity`	$245.11M	USD	Point-in-time
Balances at beginning	`StockholdersEquity`	$280.76M	USD	Point-in-time
Balances at beginning	`StockholdersEquity`	$280.76M	USD	Point-in-time
Balances at beginning	`StockholdersEquity`	$240.14M	USD	Point-in-time
Balances at beginning	`StockholdersEquity`	$240.14M	USD	Point-in-time
Balances at beginning	`StockholdersEquity`	$143.39M	USD	Point-in-time
Balances at beginning	`StockholdersEquity`	$143.39M	USD	Point-in-time
Balances at beginning	`StockholdersEquity`	$232.26M	USD	Point-in-time
Balances at beginning	`StockholdersEquity`	$232.26M	USD	Point-in-time
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$6.45M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$6.45M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$14.68M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$14.68M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$7.16M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$7.16M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$9.96M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$9.96M	USD	1 Quarter
Issuance of common stock in connection with exercise of stock options and vesting of restricted stock units	`StockIssuedDuringPeriodValueStockOptionsExerciseAndRestricedStockAwardsVesting`	$13.37M	USD	1 Quarter
Issuance of common stock in connection with exercise of stock options and vesting of restricted stock units	`StockIssuedDuringPeriodValueStockOptionsExerciseAndRestricedStockAwardsVesting`	$13.37M	USD	1 Quarter
Issuance of common stock in connection with exercise of stock options and vesting of restricted stock units	`StockIssuedDuringPeriodValueStockOptionsExerciseAndRestricedStockAwardsVesting`	$15.00K	USD	1 Quarter
Issuance of common stock in connection with exercise of stock options and vesting of restricted stock units	`StockIssuedDuringPeriodValueStockOptionsExerciseAndRestricedStockAwardsVesting`	$15.00K	USD	1 Quarter
Issuance of common stock in connection with exercise of stock options and vesting of restricted stock units	`StockIssuedDuringPeriodValueStockOptionsExerciseAndRestricedStockAwardsVesting`	$627.00K	USD	1 Quarter
Issuance of common stock in connection with exercise of stock options and vesting of restricted stock units	`StockIssuedDuringPeriodValueStockOptionsExerciseAndRestricedStockAwardsVesting`	$627.00K	USD	1 Quarter
Sale of common stock, net of issuance costs	`StockIssuedDuringPeriodValueNewIssues`	$148.96M	USD	1 Quarter
Sale of common stock, net of issuance costs	`StockIssuedDuringPeriodValueNewIssues`	$148.96M	USD	1 Quarter
Exercise of common stock warrants and pre-funded common stock warrants	`StockIssuedDuringPeriodValueExerciseOfCommonStockWarrantsAndPreFundedCommonStockWarrants`	$923.00K	USD	1 Quarter
Exercise of common stock warrants and pre-funded common stock warrants	`StockIssuedDuringPeriodValueExerciseOfCommonStockWarrantsAndPreFundedCommonStockWarrants`	$923.00K	USD	1 Quarter
Exercise of common stock warrants and pre-funded common stock warrants	`StockIssuedDuringPeriodValueExerciseOfCommonStockWarrantsAndPreFundedCommonStockWarrants`	$2.62M	USD	1 Quarter
Exercise of common stock warrants and pre-funded common stock warrants	`StockIssuedDuringPeriodValueExerciseOfCommonStockWarrantsAndPreFundedCommonStockWarrants`	$2.62M	USD	1 Quarter
Tax withholding payments for net share-settled equity awards	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$33.00K	USD	1 Quarter
Tax withholding payments for net share-settled equity awards	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$33.00K	USD	1 Quarter
Exercise of common stock warrants	`ExerciseOfCommonStockWarrants`	$2.18M	USD	1 Quarter
Exercise of common stock warrants	`ExerciseOfCommonStockWarrants`	$2.18M	USD	1 Quarter
Exercise of common stock warrants	`ExerciseOfCommonStockWarrants`	$3.01M	USD	1 Quarter
Exercise of common stock warrants	`ExerciseOfCommonStockWarrants`	$3.01M	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$537.00K	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$537.00K	USD	1 Quarter
Unrealized loss on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-139.00K	USD	1 Quarter
Unrealized loss on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-139.00K	USD	1 Quarter
Unrealized loss on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-105.00K	USD	1 Quarter
Unrealized loss on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-105.00K	USD	1 Quarter
Unrealized loss on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-153.00K	USD	1 Quarter
Unrealized loss on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-153.00K	USD	1 Quarter
Unrealized loss on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-46.00K	USD	1 Quarter
Unrealized loss on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-46.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-1.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-1.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$4.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$4.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$12.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$12.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-1.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-1.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$16.00K	USD	2 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$16.00K	USD	2 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-2.00K	USD	2 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-2.00K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-43.77M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-43.77M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-4.71M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-4.71M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-21.85M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-21.85M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-43.25M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-43.25M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-48.48M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-48.48M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-21.40M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-21.40M	USD	1 Quarter
Balances at ending	`StockholdersEquity`	$157.51M	USD	Point-in-time
Balances at ending	`StockholdersEquity`	$157.51M	USD	Point-in-time
Balances at ending	`StockholdersEquity`	$245.11M	USD	Point-in-time
Balances at ending	`StockholdersEquity`	$245.11M	USD	Point-in-time
Balances at ending	`StockholdersEquity`	$280.76M	USD	Point-in-time
Balances at ending	`StockholdersEquity`	$280.76M	USD	Point-in-time
Balances at ending	`StockholdersEquity`	$240.14M	USD	Point-in-time
Balances at ending	`StockholdersEquity`	$240.14M	USD	Point-in-time
Balances at ending	`StockholdersEquity`	$143.39M	USD	Point-in-time
Balances at ending	`StockholdersEquity`	$143.39M	USD	Point-in-time
Balances at ending	`StockholdersEquity`	$232.26M	USD	Point-in-time
Balances at ending	`StockholdersEquity`	$232.26M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.